Inquis Medical
@Inquismedical
We have fantastic news! What incepted as a mission to transform PE intervention has been substantiated by data! We are thrilled to share that hashtag#AVENTUS, our novel hashtag#thrombectomy system, designed to simplify VTE treatment and unlock clinical efficiencies, delivered…
Fireside chat with the AVENTUS Trial Co-Principal Investigators How is innovation reshaping pulmonary embolism (PE) treatment? Dr. Mehdi Shishehbor joined Dr. Jun Li and Dr. Saher Sabri, national co-principal investigators of the AVENTUS Trial, to discuss the trial's compelling…
That’s a wrap on hashtag#CVI2025! It was great connecting with so many of you at #CVI2025 and sharing the momentum behind the AVENTUS System. Thank you to everyone who stopped by—and to our incredible team for making it all happen. #AVENTUS #InquisMedical #Thrombectomy…
A huge thank you to our incredible panel and everyone who joined us at today’s CVI lunch symposium. We’re proud to showcase the data, experience, and innovation behind the AVENTUS System—and can’t wait to get this technology into the hands of those on the front lines of saving…
Heading to #CVI2025? Join us for an engaging lunch symposium on Friday, July 25, where leading physicians will share new data, real-world insights, and clinical experience with the AVENTUS Thrombectomy System. See how AVENTUS is setting a new standard in PE care. 🗓️ July…
We're excited to be at hashtag#CVI2025 Visit Inquis Medical at Booth 199 to learn how the AVENTUS System is redefining PE intervention. 🗓 July 24–26 | 📍 Austin, TX See you in Austin! #AVENTUS #InquisMedical #PulmonaryEmbolism #MedicalInnovation #Thrombectomy #CVI
Scott faced a life-threatening pulmonary embolism (PE). He walked out of the hospital the very next day. Treated with AVENTUS, the next generation of care for PE, Scott’s story is testament to innovation’s role in improved patient outcomes. Stories like Scott’s exemplify the…
It’s official! AVENTUS has been FDA cleared to treat pulmonary embolism! AVENTUS streamlines PE workflows while minimizing blood loss, the first and only thrombectomy system to integrate powerful aspiration, proprietary tissue sensing, and simplified filtered-blood reinfusion.…
A heartfelt thank you to Dr. Jun Li for her presentation of the seminal #AVENTUS IDE trial results at #SCAI2025! The dedication of our National Co-PIs, Dr. Jun Li and Dr. Saher Sabri—along with the exceptional investigators, and research teams that spanned 22 U.S. sites and…
🚨AVENTUS Trial Results presented at #SCAI2025 🔍 Key Findings: #AVENTUS #thrombectomy system safely & effectively treats intermediate-risk #PE — improving RV function, reducing clot burden, & preserving blood ➡️doi.org/10.1016/j.jsca… @saherssabri @SamHorrMD @wissamj123…
The pivotal IDE trial results for the AVENTUS Thrombectomy and Blood Filtration System have just been released. In our prospective, multi-center study, AVENTUS met its primary safety and efficacy endpoints and delivered best-in-class clinical results, significantly reducing…
The AVENTUS IDE trial, which evaluated the safety and efficacy of mechanical thrombectomy with autologous blood reinfusion for acute intermediate-risk pulmonary embolism is now published in JSCAI. In the prospective, multi-center study of 130 patients, AVENTUS met its primary…
Our defining moment is here! We’re eagerly anticipating this year’s Society for Cardiovascular Angiography & Intervention’s Scientific Sessions meeting #SCAI2025 in Washington, D.C. from May 1 to 3. Dr. Jun Li will reveal findings from the pivotal IDE trial of the #AVENTUS…
In just one week at #SCAI2025 in Washington, D.C., Dr. Jun Li will present pivotal clinical data from the #AVENTUS IDE trial. This prospective, multi-center study—conducted across 22 sites and enrolling 130 patients—was designed to evaluate the safety and efficacy of the AVENTUS…
At #SCAI2025 in Washington, D.C., Dr. Jun Li will unveil the pivotal IDE trial results for the AVENTUS Thrombectomy System in treating acute intermediate-risk pulmonary embolism (PE). Conducted across over 20 U.S. sites, this pivotal study reflects a truly comprehensive,…
A Significant Milestone in the AVENTUS Clinical Trial! We’re excited to share that patient enrollment in our AVENTUS pivotal IDE trial is officially complete! This accomplishment is the result of collective dedication and collaboration, bringing us one step closer to…
We’re proud to announce that patient enrollment in the AVENTUS pivotal IDE trial evaluating the safety and efficacy of the AVENTUS Thrombectomy System for treating pulmonary embolism, has been completed. With 130 patients enrolled across more than 20 leading U.S. clinical sites,…
Congratulations to Dr. Updesh Bedi, and the dedicated team at Ochsner Medical Center for successfully completing their 1st AVENTUS case. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology
Check out the latest article published in Endovascular Today highlighting the unmet needs in the (PE) thrombectomy space. Hear from leading experts Dr. Mehdi Shishehbor, Dr. Steven Abramowitz, and Dr. Nora Tabori. evtoday.com/articles/2024-… #PulmonaryEmbolism #EndovascularToday
